New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group - PubMed
4 hours ago
- #Histoplasmosis
- #Fungal Infection
- #Global Health
- Histoplasmosis is a neglected but deadly fungal infection, especially affecting immunocompromised individuals and those with HIV/AIDS in endemic regions.
- The disease is underdiagnosed and lacks inclusion in national surveillance systems, leading to delayed treatment and high mortality rates.
- The International Society for Human and Animal Mycology (ISHAM) formed a Histoplasmosis Working Group in 2025 to address the issue globally.
- Key challenges include diagnostic delays, underutilization of antigen testing, and limited access to essential treatments like liposomal amphotericin B and itraconazole.
- Innovations such as lateral flow assays and molecular tools were highlighted as potential solutions.
- The group proposed a 90-90-90 target by 2030 to improve diagnosis, treatment, and survival rates for histoplasmosis.